RxDoctor Payments Data

Michael Minning, MD

Family Medicine · Edgewood, KYNPI 1013974419

Payments from drug & device makers

$5,254in general payments, 2019–2025

Across 310 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$459
  • Novo Nordisk$403
  • Astellas Pharma US Inc$276
  • Amgen$243
  • Pfizer$238
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,15498%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,254 in reported general payments places this provider in the 85th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$94,214
Medicare patients
265
Services billed
2,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban87$72,530
XifaxanRifaximin14$44,409
JardianceEmpagliflozin21$34,924
JanuviaSitagliptin Phosphate29$30,226
XareltoRivaroxaban33$29,824
OzempicSemaglutide15$24,038
Janumet XrSitagliptin Phos/Metformin Hcl13$19,975
FarxigaDapagliflozin Propanediol28$18,575
MounjaroTirzepatide17$16,112
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,612
Midodrine Hcl31$10,636
Xtampza ErOxycodone Myristate11$6,933
Fluticasone Propionate HfaFluticasone Propionate13$6,117
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen147$5,762
Albuterol Sulfate HfaAlbuterol Sulfate114$3,837

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$238$73,897102 claims
MerckJanuvia, Janumet Xr$233$50,20142 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$106$44,40914 claims
Boehringer IngelheimJardiance$179$34,92421 claims
Johnson & JohnsonXarelto$105$29,82433 claims
Novo NordiskOzempic$403$24,03815 claims
AstraZenecaFarxiga$22$18,57528 claims
Lilly USA, LLCMounjaro$148$16,11217 claims
GSKTrelegy Ellipta$137$11,61218 claims
AbbVieSynthroid$1,154$2,03034 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Edgewood

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →